Similarly, patients who have a heavier burden of diabetes, such as those who require insulin or experience complications, experience family conflict, are more likely to experience negative psychological effects [121]
IV (weekly): 250 mg/week or 500 mg/week , depending on the infusion length/volume
Retatrutide is an injectable medication currently being studied for both weight management and type 2 diabetes
Mental health effects were not a primary endpoint in these studies, though adverse event reporting captured some psychiatric symptoms
Retatrutide is being studied for obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease, also called MASLD [4], [5], [6]
Based on your data, we create a custom peptide plan